HSA Approval

APO-AMITRIPTYLINE TABLET 25 mg

Approval Number

SIN00090P

Drug Name

Product Name

APO-AMITRIPTYLINE TABLET 25 mg

Approval Date

March 15, 1988

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

N06AA09

ATC Item Name

amitriptyline

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC

Active Ingredients

Ingredient Name

AMITRIPTYLINE HCl

Strength

25 mg

Drug MonographAmitriptyline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

APO-AMITRIPTYLINE TABLET 25 mg - HSA Approval | MedPath

AI-Powered Research

Premium Access

APO-AMITRIPTYLINE TABLET 25 mg

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal